eplerenone- eplerenone tablet
apotex corp - eplerenone (unii: 6995v82d0b) (eplerenone - unii:6995v82d0b) - eplerenone 25 mg - eplerenone tablets are indicated to improve survival of stable patients with left ventricular (lv) systolic dysfunction (ejection fraction ≤40%) and clinical evidence of congestive heart failure (chf) after an acute myocardial infarction (mi). eplerenone tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular (cv) events, primarily strokes and mi. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes. control of high blood pressure should be part of comprehensive cv risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s j
diovan 80mg capsules
waymade healthcare plc - valsartan - oral capsule - 80mg
valsartan 80mg capsules
dowelhurst ltd - valsartan - capsule - 80mg
diovan 160mg capsules
dowelhurst ltd - valsartan - oral capsule - 160mg
diovan 40mg tablets
novartis pharmaceuticals uk ltd - valsartan - oral tablet - 40mg
diovan 40mg tablets
waymade healthcare plc - valsartan - oral tablet - 40mg
diovan 40mg tablets
de pharmaceuticals - valsartan - oral tablet - 40mg
diovan 160mg capsules
sigma pharmaceuticals plc - valsartan - oral capsule - 160mg
diovan 160mg capsules
mawdsley-brooks & company ltd - valsartan - oral capsule - 160mg
diovan 160mg capsules
necessity supplies ltd - valsartan - oral capsule - 160mg